Granulocyte-colony stimulating factor-mobilized mesenchymal stem cells: A new resource for rapid engraftment in hematopoietic stem cell transplantation

Medical Hypotheses

Volumn 76, Issue 2, 2011, Pages 241-243

  Zhang, Cheng ^a   Zhang, Xi ^a   Chen, Xing Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BONE MARROW; CELL MATURATION; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CHEMOTHERAPY; ENGRAFTMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; RADIOTHERAPY; STEADY STATE; STEM CELL; STROMA;

ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL NUCLEUS; CLINICAL TRIALS AS TOPIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STEM CELLS; NEUTROPHILS; STEM CELLS;

EID: 78651092913     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.10.008     Document Type: Article

References (30)

1. Chen X., Zhang C., Zhang X., Gao L., Gao L., Kong P.Y., et al. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant 2009, 15:266-273.
2. Zhang C., Chen X.H., Zhang X., Gao L., Gao L., Kong P.Y., et al. Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with hematologic malignancies: the impact of donor characteristics and procedural settings. Transfuse Med 2010, 20:169-177.
3. Chen X.H., Gao L., Zhang X., Gao L., Zhang C., Kong P.Y., et al. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Blood Cells Mol Dis 2009, 43:98-104.
4. Koh L.P., Chao N.J. Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review. Blood Cells Mol Dis 2008, 40:20-24.
5. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996, 88:761-777.
6. Anderlini P., Donato M., Chan K.W., Huh Y.O., Gee A.P., Lauppe M.J., et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999, 39:555-560.
7. Brouard N, Driessen R, Short B, Enoki C, Iwasaka T, Imamura H, et al. G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving osteoclast-mediated bone resorption. Stem Cell Res 2010. doi:10.1016/j.scr.2010.04.002. doi:10.1016/j.scr.2010.04.002.
8. Ripa R.S., Haack-Sørensen M., Wang Y., Jørgensen E., Mortensen S., Bindslev L., et al. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the stem cells in myocardial infarction (STEMMI) trial. Circulation 2007, 116:124-130.
9. Tatsumi K., Otani H., Sato D., Enoki C., Iwasaka T., Imamura H., et al. Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J 2008, 72:1351-1358.
10. Cesselli D., Beltrami A.P., Rigo S., Bergamin N., D'Aurizio F., Verardo R., et al. Multipotent progenitor cells are present in human peripheral blood. Circ Res 2009, 104:1225-1234.
11. Chang YJ, Huang XJ. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin Transplant 2010. doi:10.1111/j.1399-0012.2010.01298.x. doi:10.1111/j.1399-0012.2010.01298.x.
12. Huang X.J., Han W., Xu L.P., Chen Y.H., Liu D.H., Lu J., et al. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Chin Med J 2004, 117:1778-1785.
13. Fliedner T.M., Graessle D., Paulsen C., Reimers K. Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure. Cancer Biother Radiopharm 2002, 17:405-426.
14. Tavassoli M. Structure and function of sinusoidal endothelium of bone marrow. Prog Clin Biol Res 1981, 59B:249-256.
15. Scott L.M., Priestley G.V., Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 2003, 23:9349-9360.
16. Ulyanova T., Scott L.M., Priestley G.V., Jiang Y., Nakamoto B., Koni P.A., et al. VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin. Blood 2005, 106:86-94.
17. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
18. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hubel K., Cooper S., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003, 102:2728-2730.
19. Clark B.R., Keating A. Biology of bone marrow stroma. Ann N Y Acad Sci 1995, 770:70-78.
20. Verfaillie C., Hurley R., Bhatia R., McCarthy J.B. Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit Rev Oncol Hematol 1994, 16:201-224.
21. Dazzi F., Ramasamy R., Glennie S., Jones S.P., Roberts I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev 2006, 20:161-171.
22. Al-Khaldi A., Eliopoulos N., Martineau D., Lejeune L., Lachapelle K., Galipeau J. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 2003, 10:621-629.
23. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
24. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001, 98:2615-2625.
25. Kemp K.C., Hows J., Donaldson C. Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 2005, 46:1531-1544.
26. Roorda B.D., ter Elst A., Kamps W.A., de Bont E.S. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor microenvironments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol 2009, 69:187-198.
27. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28:875-884.
28. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392:565-568.
29. Milne C.D., Fleming H.E., Zhang Y., Paige C.J. Mechanisms of selection mediated by interleukin-7, the preBCR, and hemokinin-1 during B-cell development. Immunol Rev 2004, 197:75-88.
30. Barda-Saad M., Rozenszajn L.A., Globerson A., Zhang A.S., Zipori D. Selective adhesion of immature thymocytes to bone marrow stromal cells: relevance to T cell lymphopoiesis. Exp Hematol 1996, 24:386-391.